Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M75.9Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-1.8
Enterprise Value $M8.0EPS (TTM) $-2.6Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio6.2Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio6.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-61.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.7ROIC % (ttm)-377.9Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LIFEMario Gabelli 2014-03-31 Sold Out -0.47%$75.75 - $76.07
($75.91)
$ 3.20-96%Sold Out0
LIFEJoel Greenblatt 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.20-96%Sold Out0
LIFEJohn Paulson 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.20-96%Sold Out0
LIFEJohn Paulson 2013-12-31 Reduce-0.04%$74.72 - $75.78
($75.43)
$ 3.20-96%Reduce -50.48%89,657
LIFEFirst Eagle Investment 2013-12-31 Reduce-0.03%$74.72 - $75.78
($75.43)
$ 3.20-96%Reduce -63.70%72,600
LIFEJoel Greenblatt 2013-12-31 Add0.02%$74.72 - $75.78
($75.43)
$ 3.20-96%Add 320.36%14,885
LIFEJohn Paulson 2013-09-30 Reduce-0.58%$74.06 - $74.96
($74.61)
$ 3.20-96%Reduce -85.90%181,053
LIFEFirst Eagle Investment 2013-09-30 Reduce-0.06%$74.06 - $74.96
($74.61)
$ 3.20-96%Reduce -56.11%200,000
LIFEJoel Greenblatt 2013-09-30 Reduce-0.02%$74.06 - $74.96
($74.61)
$ 3.20-96%Reduce -67.32%3,541
LIFEJohn Paulson 2013-06-30 Reduce-4.93%$64.57 - $74.41
($72.6)
$ 3.20-96%Reduce -91.31%1,284,433
LIFEJohn Rogers 2013-06-30 Sold Out -1.9%$64.57 - $74.41
($72.6)
$ 3.20-96%Sold Out0
LIFERobert Olstein 2013-06-30 Sold Out -1.1%$64.57 - $74.41
($72.6)
$ 3.20-96%Sold Out0
LIFEMeridian Funds 2013-06-30 Sold Out -0.83%$64.57 - $74.41
($72.6)
$ 3.20-96%Sold Out0
LIFERonald Muhlenkamp 2013-06-30 Sold Out -0.67%$64.57 - $74.41
($72.6)
$ 3.20-96%Sold Out0
LIFEMario Gabelli 2013-06-30 Add0.59%$64.57 - $74.41
($72.6)
$ 3.20-96%Add 3187.35%1,311,520
LIFEFirst Eagle Investment 2013-06-30 Buy 0.1%$64.57 - $74.41
($72.6)
$ 3.20-96%New holding455,735
LIFEJoel Greenblatt 2013-06-30 Reduce-0.02%$64.57 - $74.41
($72.6)
$ 3.20-96%Reduce -33.08%10,836
LIFERonald Muhlenkamp 2013-03-31 Reduce-1.77%$49.03 - $65.27
($60.09)
$ 3.20-95%Reduce -76.85%50,000
LIFERobert Olstein 2013-03-31 Reduce-0.62%$49.03 - $65.27
($60.09)
$ 3.20-95%Reduce -38.51%99,000
LIFEJohn Paulson 2013-03-31 Add0.28%$49.03 - $65.27
($60.09)
$ 3.20-95%Add 5.53%14,773,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LIFE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHIMMEL PAULDirector 2016-12-21Buy25,000$2.2840.35view
Amanullah AshrafVice President, Manufacturing 2016-12-20Buy11,000$2.2542.22view
MENDLEIN JOHNCEO and Director 2016-12-19Buy69,000$2.245.45view
SCHIMMEL PAULDirector 2016-12-16Buy50,000$2.4829.03view
Matsuoka GroveSee Remarks 2016-05-11Buy12,412$3.045.26view
SCHIMMEL PAULDirector 2016-04-14Buy66,219$4.18-23.44view
SCHIMMEL PAULDirector 2016-04-13Buy9,835$3.85-16.88view
SCHIMMEL PAULDirector 2016-04-12Buy9,127$3.71-13.75view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-10.36view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.57-10.36view

Press Releases about LIFE :

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com

More From Other Websites
8:02 am aTyr Pharma: FDA grants Fast Track Designation for aTyr's Resolaris to treat limb girdle... Jan 18 2017
FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B... Jan 18 2017
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure Jan 09 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares Dec 21 2016
Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? Dec 16 2016
aTyr Pharma downgraded by JP Morgan Dec 13 2016
aTyr Pharma Drops on Clinical Update Dec 13 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Dec 13 2016
aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare Genetically Distinct... Dec 13 2016
aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference Dec 09 2016
aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016 Dec 05 2016
ATYR PHARMA INC Financials Nov 23 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
ATYR PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Nov 21 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session Nov 18 2016
aTyr Pharma Announces Third Quarter 2016 Operating Results Nov 14 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)